Cases & Deals

Bay City Capital and Panorama Capital invest in Hyperion Therapeutics

Clients Bay City Capital and Panorama Capital

Jones Day counseled Bay City Capital and Panorama Capital in connection with their purchase of $60 million of Series C Convertible Preferred Stock, along with Highland Capital Partners, NEA, Sofinnova Ventures, and WRF Capital, in a private placement by Hyperion Therapeutics, a privately held specialty biopharmaceutical company.